HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Meihui Luo Selected Research

Emphysema

1/2017Distinct Roles of Wnt/β-Catenin Signaling in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Meihui Luo Research Topics

Disease

10Cystic Fibrosis (Mucoviscidosis)
10/2020 - 09/2005
4Infections
03/2016 - 09/2005
3Lung Diseases (Lung Disease)
01/2018 - 01/2017
3Ischemia
07/2013 - 03/2004
2Neoplasms (Cancer)
01/2018 - 02/2017
2Chronic Obstructive Pulmonary Disease (COPD)
01/2018 - 01/2017
2Lung Neoplasms (Lung Cancer)
01/2018 - 02/2017
2Fibrosis (Cirrhosis)
10/2017 - 01/2017
2Inflammation (Inflammations)
10/2017 - 03/2004
2Pneumonia (Pneumonitis)
10/2017 - 01/2017
1Obstructive Lung Diseases (Obstructive Lung Disease)
01/2022
1Adenocarcinoma
01/2018
1Adenocarcinoma of Lung
01/2018
1Chronic Bronchitis
01/2018
1Pulmonary Fibrosis (Fibrosing Alveolitis)
10/2017
1Idiopathic Pulmonary Fibrosis
01/2017
1Emphysema
01/2017
1Inborn Genetic Diseases (Disease, Hereditary)
11/2013
1Hypoxia (Hypoxemia)
07/2013
1Bacterial Infections (Bacterial Infection)
08/2011
1Meconium Ileus
09/2010
1Weight Gain
09/2010
1Lung Injury
02/2009
1Reperfusion Injury
03/2008
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
02/2008
1Motor Neuron Disease (Primary Lateral Sclerosis)
10/2007
1Wounds and Injuries (Trauma)
03/2004

Drug/Important Bio-Agent (IBA)

5Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
01/2018 - 09/2005
2Proteins (Proteins, Gene)FDA Link
01/2018 - 03/2004
2ChloridesIBA
01/2018 - 09/2010
2CytokinesIBA
10/2017 - 03/2016
2Toll-Like Receptors (Toll-Like Receptor)IBA
10/2017 - 03/2016
2Chloride Channels (Chloride Channel)IBA
11/2013 - 08/2011
2NADPH Oxidases (NAD(P)H oxidase)IBA
07/2013 - 10/2007
1AnionsIBA
01/2018
1ivacaftorIBA
01/2018
1AntioxidantsIBA
01/2018
1Bicarbonates (Hydrogen Carbonate)IBA
01/2018
1Expectorants (Mucolytics)IBA
01/2018
1Ion Channels (Ion Channel)IBA
01/2018
1RoflumilastIBA
01/2018
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2018
1NicotineFDA Link
01/2018
1SmokeIBA
01/2018
1Transcription Factors (Transcription Factor)IBA
01/2018
1Bleomycin (Blenoxane)FDA LinkGeneric
10/2017
1Hydroxyproline (4 Hydroxyproline)IBA
10/2017
1indium-bleomycinIBA
10/2017
1MicroRNAs (MicroRNA)IBA
02/2017
1CateninsIBA
01/2017
1Myeloid Differentiation Factor 88IBA
03/2016
1Pathogen-Associated Molecular Pattern MoleculesIBA
03/2016
1Coloring Agents (Dyes)IBA
03/2016
1BCG VaccineFDA Link
03/2016
1LigandsIBA
03/2016
1AntigensIBA
12/2015
1VaccinesIBA
12/2015
1NADPH Oxidase 1IBA
07/2013
1Reactive Oxygen Species (Oxygen Radicals)IBA
07/2013
1Proton Pump InhibitorsIBA
09/2010
1Ursodeoxycholic Acid (Urso)FDA LinkGeneric
09/2010
1NucleotidesIBA
02/2009
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
03/2008
1Superoxide Dismutase-1IBA
02/2008
1Messenger RNA (mRNA)IBA
09/2005
1NF-kappa B (NF-kB)IBA
03/2004
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2004
1NF-KappaB Inhibitor alphaIBA
03/2004
1I kappa B beta proteinIBA
03/2004
1EndotoxinsIBA
03/2004

Therapy/Procedure

6Therapeutics
01/2022 - 01/2006
1Oral Administration
09/2010